Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.24.2.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net increase (decrease) in net assets resulting from operations $ 424,147 $ 304,947
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net change in unrealized (appreciation) depreciation on investments (52,015) (115,990)
Net realized (gain) loss on investments 11,474 10,366
Net change in unrealized (appreciation) depreciation on foreign currency forward contracts (17,248) (904)
Net change in unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies (13,913) 7,696
Net accretion of discount and amortization of premium, net (47,986) (17,778)
Amortization of deferred financing costs 4,371 2,738
Amortization of debt issuance costs and original issue discount on notes 3,247 809
Amortization of offering costs 816 754
Payment-in-kind interest capitalized (34,077) (12,458)
Payment-in-kind dividends capitalized (954) 0
Purchases of investments (3,018,927) (1,539,183)
Proceeds from sale of investments and principal repayments 1,309,690 366,205
Changes in operating assets and liabilities:    
Interest receivable from non-controlled/non-affiliated investments (12,664) (5,083)
Dividend receivable from non-controlled/non-affiliated investments 56 0
Receivable for investments 91,122 (8,945)
Other assets (18,401) (556)
Payable for investments purchased 4,566 35,370
Interest payable 18,981 22,176
Due to affiliates (1,847) 6,491
Management fees payable 1,738 4,096
Income based incentive fees payable 6,678 17,211
Capital gains incentive fees payable 9,528 0
Distribution and/or shareholder servicing fees payable 431 1,257
Accrued expenses and other liabilities (938) (783)
Net cash provided by (used in) operating activities (1,332,125) (921,564)
Cash flows from financing activities:    
Borrowings on debt 3,062,601 2,253,726
Repayments of debt (2,963,128) (1,456,808)
Deferred financing costs paid (8,642) (11,416)
Debt issuance costs paid (48,543) (3,646)
Deferred offering costs paid (1,514) (1,511)
Proceeds from issuance of Common Shares 1,772,325 399,387
Common Shares repurchased, net of early repurchase deduction (123,000) (35,589)
Distributions paid in cash (195,619) (108,992)
Net cash provided by (used in) financing activities 1,494,480 1,035,151
Net increase (decrease) in cash and cash equivalents 162,355 113,587
Cash and cash equivalents, beginning of period 188,775 74,241
Cash and cash equivalents, end of period 351,130 187,828
Supplemental information and non-cash activities:    
Interest paid during the period 148,162 89,387
Taxes paid during the period 1,522 819
Distribution payable 58,234 32,319
Share repurchases accrued but not paid 56,104 98,594
Reinvestment of distributions during the period 134,636 74,599
Non-cash purchases of investments 3,045 28,861
Non-cash sales of investments $ (3,045) $ (28,861)